Increased frequency of disease-causing MYH mutations in colon cancer families

Carcinogenesis

Volumn 27, Issue 11, 2006, Pages 2243-2249

  Peterlongo, Paolo ^a   Mitra, Nandita ^b   de Abajo, Ana Sanchez ^c   de la Hoya, Miguel ^c   Bassi, Chiara ^d   Bertario, Lucio ^e   Radice, Paolo ^d,e   Glogowski, Emily ^a   Nafa, Khedoudja ^a   Caldes, Trinidad ^c   Offit, Kenneth ^a   Ellis, Nathan A ^f  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

^f UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID BINDING PROTEIN; PROTEIN MYH; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CLUSTER ANALYSIS; COLON CANCER; COLON CARCINOGENESIS; COLON POLYPOSIS; CONTROLLED STUDY; DOMINANT INHERITANCE; ETHNIC GROUP; FAMILY STUDY; FEMALE; FISHER EXACT TEST; FREQUENCY ANALYSIS; GENE DELETION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HEREDITY; HUMAN; HUMAN CELL; HYPOTHESIS; JEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; PEDIGREE ANALYSIS; PENETRANCE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; DNA GLYCOSYLASES; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION;

EID: 33750460975     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl093     Document Type: Article

References (29)

1. Lynch,H.T. and de la Chapelle,A. (1999) Genetic susceptibility to nonpolyposis colorectal cancer. J. Med. Genet., 36, 801-818.
2. de la Chapelle,A. (2004) Genetic predisposition to colorectal cancer. Nat. Rev. Cancer, 10, 769-780.
3. Vasen,H.F., Mecklin,J.P., Watson,P. et al. (1993) Surveillance in hereditary nonpolyposis colorectal cancer: An international cooperative study of 165 families. The International Collaborative Group on HNPCC. Dis. Colon Rectum, 36, 1-4.
4. Vasen,H.F., Watson,P., Mecklin,J.P. and Lynch,H.T. (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology, 116, 1453-1456.
5. Moslein,G., Tester,D.J., Lindor,N.M., Honchel,R., Cunningham,J.M., French,A.J., Halling,K.C., Schwab,M., Goretzki,P. and Thibodeau,S.N. (1996) Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. Hum. Mol. Genet., 5, 1245-1252.
6. Wijnen,J., Khan,P.M., Vasen,H., van der Klift,H., Mulder,A., van Leeuwen-Cornelisse,I., Bakker,B., Losekoot,M., Moller,P. and Fodde,R. (1997) Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations. Am. J. Hum. Genet., 61, 329-335.
7. Houlston,R.S. and Peto,J. (2004) The search for low-penetrance cancer susceptibility alleles. Oncogene, 23, 6471-6476.
8. Pharoah,P.D., Antoniou,A., Bobrow,M., Zimmern,R.L., Easton,D.F. and Ponder,B.A. (2004) Polygenic susceptibility to breast cancer and implications for prevention. Nat. Genet., 31, 33-36.
9. Laken,S.J., Petersen,G.M., Gruber,S.B. et al. (1997) Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat. Genet., 17, 79-83.
10. Meijers-Heijboer,H., van den Ouweland,A., Klijn,J. et al. (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(* 1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat. Genet., 31, 55-59.
11. Locker,G.Y. and Lynch,H.T. (2004) Genetic factors and colorectal cancer in Ashkenazi Jews. Fam. Cancer, 3, 215-221.
12. CHEK2 Breast Cancer Case Control Consortium (2004) CHEK2*1100delC and susceptibility to breast cancer: A collaborative analysis involving 10 860 breast cancer cases and 9065 controls from 10 studies. Am. J. Hum. Genet., 74, 1175-1182.
13. Al-Tassan,N., Chmiel,N.H., Maynard,J. et al. (2002) Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat. Genet., 30, 227-232.
14. Sieber,O.M., Lipton,L., Crabtree,M. et al. (2003) Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N. Engl. J. Med., 348, 791-799.
15. Enholm,S., Hienonen,T., Suomalainen,A. et al. (2003) Proportion and phenotype of MYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients. Am. J. Pathol., 163, 827-832.
16. Fleischmann,C., Peto,J., Cheadle,J., Shah,B., Sampson,J. and Houlston,R.S. (2004) Comprehensive analysis of the contribution of germline MYH variation to early-onset colorectal cancer. Int. J. Cancer, 109, 554-558.
17. Croitoru,M.E., Cleary,S.P., Di Nicola,N. et al. (2004) Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J. Natl. Cancer Inst., 96, 1631-1634.
18. Wang,L., Baudhuin,L.M., Boardman,L.A. et al. (2004) MYE mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology, 127, 9-16.
19. Gismondi,V., Meta,M., Bonelli,L. et al. (2004) Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas. Int. J. Cancer, 109, 680-684.
20. Peterlongo,P., Mitra,M., Chuai,S., Kirchhoff,T., Palmer,C., Huang,H., Nafa,K., Offit,K. and Ellis,N.A. (2005) Colorectal cancer risk in individuals with biallelic or monoallelic mutations of MYH. Int. J. Cancer, 114, 505-507.
21. Farrington,S.M., Tenesa,A., Barnetson,R., Wiltshire,A., Prendergast,J., Porteous,M., Campbell,H. and Dunlop,M.G. (2005) Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am. J. Hum. Genet., 77, 112-119.
22. Zhou,X.L., Djureinovic,T., Werelius,B., Lindmark,G., Sun,X.F. and Lindblom,A. and the Swedish Low-Risk Colorectal Cancer Group (2005) Germline mutations in the MYH gene in Swedish familial and sporadic colorectal cancer. Genet. Test, 9, 147-151.
23. Peterlongo,P., Nafa,K., Lerman,G.S. et al. (2003) MSH6 germline mutations are rare in colorectal cancer families. Int. J. Cancer, 107, 571-579.
24. Shia,J., Klimstra,D.S., Nafa,K., Offit,K., Guillem,J.G., Markowitz,A.J., Gerald,W.L. and Ellis,N.A. (2005) Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Am. J. Surg. Pathol., 291, 96-104.
25. Jenkins,M.A., Croitoru,M.E., Monga,N., Cleary,S.P., Cotterchio,M., Hopper,J.L. and Gallinger,S. (2006) Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: A population-based case-family study. Cancer Epidemiol. Biomarkers Prev., 15, 312-314.
26. Jo,W.S., Bandipalliam,P., Shannon,K.M., Niendorf,K.B., Chan-Smutko, G., Hur,C., Syngal,S. and Chung,D.C. (2005) Correlation of polyp number and family history of colon cancer with germline MYH mutations. Clin. Gastroenterol. Hepatol., 3, 1022-1028.
27. Ashton,K.A., Meldrum,C.J., McPhillips,M.L., Kairupan,C.F. and Scott,R.J. (2005) Frequency of the common MYH mutations (G382D and Y165C) in MMR mutation positive and negative HNPCC patients. Hereditary Cancer Clin. Pract., 3, 65-70.
28. Pasche,B., Kolachana,P., Nafa,K. et al. (1999) ThetaR-I(6A) is a candidate tumor susceptibility allele. Cancer. Res., 59, 5678-5682.
29. Bian,Y., Caldes,T., Wijnen,J. et al. (2005) TGFBR1*6A may contribute to hereditary colorectal cancer. J. Clin. Oncol., 23, 3074-3078.